Doyle Anthony - Insider Non-Derivative Transactions at BIOCRYST PHARMACEUTICALS INC (BCRX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 14, 2024, Doyle Anthony's relationship to BIOCRYST PHARMACEUTICALS INC (BCRX) is Officer (Chief Financial Officer), and currently has 266,744 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other BCRX insiders.
Data Source: SEC.
Doyle Anthony - Insider Non-Derivative Transactions of BCRX Common Stock
Doyle Anthony - Insider Non-Derivative Transactions at BCRX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| May 15, 2024 | P -- (Common Stock) | 36300 | 5.57 | 266744 |
| Dec 20, 2023 | F -- (Common Stock) | 2482 | 6.05 | 227444 |
| Dec 15, 2023 | F -- (Common Stock) | 5475 | 6.43 | 229926 |
| Dec 15, 2023 | Acquisition -- (Common Stock) | 34000 | 0 | 235401 |